Skip to main content

Search UC San Diego Today

Keyword is required

Your search for “Novel Treatment” returned 433 results

Cancer Treatment of Tomorrow, Today

Moores Cancer Center continues to bring state-of-the-art cancer treatments from the bench to the bedside.

Novel Surgery May Prevent Lymphedema in Patients with Breast Cancer

Of the 3.5 million breast cancer survivors in the US, 1 in 5 will be diagnosed with a painful swelling condition called lymphedema, which can occur as a consequence of lymph nodes being removed. UC San Diego Health now offers a novel surgical procedure to help prevent this debilitating condition.

Magnetic Seizure Therapy may be Attractive Alternative to Electricity

In novel study, an international research team investigated whether continued magnetic seizure therapy might effectively prevent the relapse of treatment-resistant depression, compared to what is known about electroconvulsive therapy, the current standard of care.

New Clinic Matches Patients with Cancer to Latest Precision Immunotherapy Treatments

New Precision Immunotherapy Therapy clinic at Moores Cancer Center at UC San Diego Health matches patients using genetic profiling to personalized cancer treatment plans.

Same Treatment Tested for Kids with Kawasaki Disease and Rare COVID-19 Reaction

Researchers at University of California San Diego School of Medicine tested the same treatment for kids with Kawasaki disease and rare COVID-19 reaction.

Novel Antisense Drug Shows Promise in Slowing Fatty Liver Disease

A first-in-class clinical trial suggests a novel treatment measurably slowed progression of non-alcoholic fatty liver disease to its more progressive and deadly form.

Novel Treatment Approach to Alzheimer’s Disease Uses Vitamin B1 Derivative

With a $45 million grant from the NIH, UC San Diego researchers and collaborators will launch a nationwide clinical trial to further investigate the therapeutic potential of benfotiamine, a synthetic version of thiamine (B1), as a treatment for Alzheimer’s disease.

NSF Awards More than $1 Million to Interdisciplinary Research Team to Study Chronic Low Back Pain

A multidisciplinary team led by researchers at UC San Diego has received $1.2 million from the National Science Foundation (NSF) to create a novel system to study and inform the treatment of chronic low back pain.

Injection of Virus-Delivered Gene Silencer Blocks ALS Degeneration, Saves Motor Function

Novel spinal therapy/delivery approach prevented disease onset in neurodegenerative ALS disease model in adult mice and blocked progression in animals already showing disease symptoms.

CAR Trials Drive Leukemia and Lymphoma Treatment in New Direction

…trials to test the safety and efficacy of a novel cellular-immunotherapy that uses modified T cells – one of the immune system’s primary weapons – to treat three different types of blood cancer that often defy existing therapies.